Exploratory analysis of the economically justifiable price of reslizumab for asthma severe in Colombia
{{output}}
Introduction: Asthma severe imposes important economic burden for health systems, especially with the incorporation of new drugs. Recently, reslizumab has been approved to prevent exacerbations in patients with eosinophilic asthm... ...
